Annual Net Income
-$258.13 M
+$66.97 M+20.60%
December 31, 2024
Summary
- As of March 12, 2025, SWTX annual net profit is -$258.13 million, with the most recent change of +$66.97 million (+20.60%) on December 31, 2024.
- During the last 3 years, SWTX annual net income has fallen by -$84.22 million (-48.43%).
- SWTX annual net income is now -1349.12% below its all-time high of -$17.81 million, reached on December 31, 2018.
Performance
SWTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$77.30 M
-$23.77 M-44.40%
December 31, 2024
Summary
- As of March 12, 2025, SWTX quarterly net profit is -$77.30 million, with the most recent change of -$23.77 million (-44.40%) on December 31, 2024.
- Over the past year, SWTX quarterly net income has dropped by -$37.38 million (-93.63%).
- SWTX quarterly net income is now -785.74% below its all-time high of $11.27 million, reached on December 31, 2020.
Performance
SWTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$258.13 M
+$17.02 M+6.19%
December 31, 2024
Summary
- As of March 12, 2025, SWTX TTM net profit is -$258.13 million, with the most recent change of +$17.02 million (+6.19%) on December 31, 2024.
- Over the past year, SWTX TTM net income has increased by +$42.93 million (+14.26%).
- SWTX TTM net income is now -5058.49% below its all-time high of -$5.00 million, reached on September 30, 2018.
Performance
SWTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
SWTX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.6% | -93.6% | +14.3% |
| 3 y3 years | -48.4% | -93.6% | +14.3% |
| 5 y5 years | -342.7% | -93.6% | +14.3% |
SWTX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -48.4% | +20.6% | -93.6% | +18.1% | -48.4% | +23.9% |
| 5 y | 5-year | -466.4% | +20.6% | -785.7% | +18.1% | -466.4% | +23.9% |
| alltime | all time | -1349.1% | +20.6% | -785.7% | +18.1% | -5058.5% | +23.9% |
SpringWorks Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$258.13 M(-20.6%) | -$77.30 M(+44.4%) | -$258.13 M(-6.2%) |
| Sep 2024 | - | -$53.53 M(+34.1%) | -$275.16 M(-8.6%) |
| Jun 2024 | - | -$39.92 M(-54.3%) | -$301.06 M(-11.2%) |
| Mar 2024 | - | -$87.39 M(-7.4%) | -$339.07 M(+4.3%) |
| Dec 2023 | -$325.10 M(+17.2%) | -$94.32 M(+18.7%) | -$325.10 M(+6.6%) |
| Sep 2023 | - | -$79.44 M(+1.9%) | -$304.96 M(+2.4%) |
| Jun 2023 | - | -$77.92 M(+6.1%) | -$297.91 M(+3.1%) |
| Mar 2023 | - | -$73.42 M(-1.0%) | -$289.04 M(+4.2%) |
| Dec 2022 | -$277.42 M(+59.5%) | -$74.18 M(+2.5%) | -$277.42 M(+7.0%) |
| Sep 2022 | - | -$72.39 M(+4.8%) | -$259.31 M(+13.8%) |
| Jun 2022 | - | -$69.05 M(+11.7%) | -$227.96 M(+10.7%) |
| Mar 2022 | - | -$61.80 M(+10.2%) | -$205.92 M(+18.4%) |
| Dec 2021 | -$173.91 M | -$56.07 M(+36.6%) | -$173.91 M(+63.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$41.04 M(-12.7%) | -$106.57 M(+22.2%) |
| Jun 2021 | - | -$47.01 M(+57.8%) | -$87.18 M(+45.1%) |
| Mar 2021 | - | -$29.79 M(-364.3%) | -$60.07 M(+31.8%) |
| Dec 2020 | -$45.57 M(-21.8%) | $11.27 M(-152.0%) | -$45.57 M(-37.6%) |
| Sep 2020 | - | -$21.66 M(+8.9%) | -$73.06 M(+7.1%) |
| Jun 2020 | - | -$19.89 M(+30.1%) | -$68.24 M(+9.7%) |
| Mar 2020 | - | -$15.29 M(-5.7%) | -$62.19 M(+6.7%) |
| Dec 2019 | -$58.31 M(+227.3%) | -$16.22 M(-3.7%) | -$58.31 M(+20.7%) |
| Sep 2019 | - | -$16.83 M(+21.6%) | -$48.31 M(+32.4%) |
| Jun 2019 | - | -$13.85 M(+21.4%) | -$36.48 M(+61.2%) |
| Mar 2019 | - | -$11.41 M(+83.5%) | -$22.63 M(+101.7%) |
| Dec 2018 | -$17.81 M | -$6.22 M(+24.3%) | -$11.22 M(+124.3%) |
| Sep 2018 | - | -$5.00 M | -$5.00 M |
FAQ
- What is SpringWorks Therapeutics annual net profit?
- What is the all time high annual net income for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics annual net income year-on-year change?
- What is SpringWorks Therapeutics quarterly net profit?
- What is the all time high quarterly net income for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics quarterly net income year-on-year change?
- What is SpringWorks Therapeutics TTM net profit?
- What is the all time high TTM net income for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics TTM net income year-on-year change?
What is SpringWorks Therapeutics annual net profit?
The current annual net income of SWTX is -$258.13 M
What is the all time high annual net income for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high annual net profit is -$17.81 M
What is SpringWorks Therapeutics annual net income year-on-year change?
Over the past year, SWTX annual net profit has changed by +$66.97 M (+20.60%)
What is SpringWorks Therapeutics quarterly net profit?
The current quarterly net income of SWTX is -$77.30 M
What is the all time high quarterly net income for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high quarterly net profit is $11.27 M
What is SpringWorks Therapeutics quarterly net income year-on-year change?
Over the past year, SWTX quarterly net profit has changed by -$37.38 M (-93.63%)
What is SpringWorks Therapeutics TTM net profit?
The current TTM net income of SWTX is -$258.13 M
What is the all time high TTM net income for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high TTM net profit is -$5.00 M
What is SpringWorks Therapeutics TTM net income year-on-year change?
Over the past year, SWTX TTM net profit has changed by +$42.93 M (+14.26%)